BioSpace News Archive

Press Releases

FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

December 16, 2024
·
9 min read
Press Releases

Accolade to Announce Fiscal Third Quarter 2025 Financial Results

December 16, 2024
·
1 min read
Press Releases

BioAtla Presented Data Characterizing Mutated KRAS Genotype and Clinical Outcomes in Patients with Advanced NSCLC Treated with Mecbotamab Vedotin (Mec-V), a CAB-AXL-ADC, at the IASLC 2024 Hot Topic in Basic & Translational Science Meeting

December 16, 2024
·
7 min read
Press Releases

Daré Bioscience Announces Phase 3 Plans for Sildenafil Cream, 3.6%, in the Treatment of Female Sexual Arousal Disorder (FSAD)

December 16, 2024
·
14 min read
Press Releases

BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards

December 16, 2024
·
2 min read
Press Releases

Arcutis Submits ZORYVE® (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis

December 16, 2024
·
7 min read
Press Releases

Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference

December 16, 2024
·
7 min read
Press Releases

Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update

December 16, 2024
·
8 min read
Press Releases

Arthrosi Appoints John Leaman, M.D., to Its Board of Directors

December 16, 2024
·
3 min read
Press Releases

LIB Therapeutics Submits a Biologic License Application to FDA for Lerodalcibep for the Treatment of Adults with Elevated LDL-Cholesterol

December 16, 2024
·
4 min read